Publication: Early Height and Weight Changes in Children Using Cotrimoxazole Prophylaxis with Antiretroviral Therapy
Issued Date
2016-11-01
Resource Type
ISSN
15376591
10584838
10584838
Other identifier(s)
2-s2.0-84994504610
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Infectious Diseases. Vol.63, No.9 (2016), 1236-1244
Suggested Citation
David C. Boettiger, Dina Muktiarti, Nia Kurniati, Khanh H. Truong, Suneeta Saghayam, Penh Sun Ly, Rawiwan Hansudewechakul, Lam Van Nguyen, Viet Chau Do, Tavitiya Sudjaritruk, Pagakrong Lumbiganon, Kulkanya Chokephaibulkit, Torsak Bunupuradah, Nik Khairulddin Nik Yusoff, Dewi Kumara Wati, Kamarul Azahar Mohd Razali, Moy Siew Fong, Revathy A. Nallusamy, Annette H. Sohn, Azar Kariminia Early Height and Weight Changes in Children Using Cotrimoxazole Prophylaxis with Antiretroviral Therapy. Clinical Infectious Diseases. Vol.63, No.9 (2016), 1236-1244. doi:10.1093/cid/ciw514 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/41060
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Early Height and Weight Changes in Children Using Cotrimoxazole Prophylaxis with Antiretroviral Therapy
Author(s)
David C. Boettiger
Dina Muktiarti
Nia Kurniati
Khanh H. Truong
Suneeta Saghayam
Penh Sun Ly
Rawiwan Hansudewechakul
Lam Van Nguyen
Viet Chau Do
Tavitiya Sudjaritruk
Pagakrong Lumbiganon
Kulkanya Chokephaibulkit
Torsak Bunupuradah
Nik Khairulddin Nik Yusoff
Dewi Kumara Wati
Kamarul Azahar Mohd Razali
Moy Siew Fong
Revathy A. Nallusamy
Annette H. Sohn
Azar Kariminia
Dina Muktiarti
Nia Kurniati
Khanh H. Truong
Suneeta Saghayam
Penh Sun Ly
Rawiwan Hansudewechakul
Lam Van Nguyen
Viet Chau Do
Tavitiya Sudjaritruk
Pagakrong Lumbiganon
Kulkanya Chokephaibulkit
Torsak Bunupuradah
Nik Khairulddin Nik Yusoff
Dewi Kumara Wati
Kamarul Azahar Mohd Razali
Moy Siew Fong
Revathy A. Nallusamy
Annette H. Sohn
Azar Kariminia
Other Contributor(s)
University of New South Wales (UNSW) Australia
University of Indonesia, RSUPN Dr. Cipto Mangunkusumo
Children's Hospital 1
YR Gaitonde Centre for AIDS Research and Education
National Center for HIV/AIDS
Chiangrai Prachanukroh Hospital
National Hospital of Pediatrics Hanoi
Children's Hospital 2
Chiang Mai University
Khon Kaen University
Mahidol University
The HIV Netherlands Australia Thailand Research Collaboration
Hospital Raja Perempuan Zainab II
Universitas Udayana
Kuala Lumpur Hospital
Hospital Likas
Penang Hospital
amfAR - The Foundation for AIDS Research
University of Indonesia, RSUPN Dr. Cipto Mangunkusumo
Children's Hospital 1
YR Gaitonde Centre for AIDS Research and Education
National Center for HIV/AIDS
Chiangrai Prachanukroh Hospital
National Hospital of Pediatrics Hanoi
Children's Hospital 2
Chiang Mai University
Khon Kaen University
Mahidol University
The HIV Netherlands Australia Thailand Research Collaboration
Hospital Raja Perempuan Zainab II
Universitas Udayana
Kuala Lumpur Hospital
Hospital Likas
Penang Hospital
amfAR - The Foundation for AIDS Research
Abstract
© The Author 2016. Background. The growth benefits of cotrimoxazole during early antiretroviral therapy (ART) are not well characterized. Methods. Individuals enrolled in the Therapeutics Research, Education, and AIDS Training in Asia Pediatric HIV Observational Database were included if they started ART at ages 1 month-14 years and had both height and weight measurements available at ART initiation (baseline). Generalized estimating equations were used to identify factors associated with change in height-for-age z-score (HAZ), follow-up HAZ ≥ -2, change in weight-for-age z-score (WAZ), and follow-up WAZ ≥ -2. Results. A total of 3217 children were eligible for analysis. The adjusted mean change in HAZ among cotrimoxazole and non-cotrimoxazole users did not differ significantly over the first 24 months of ART. In children who were stunted (HAZ < -2) at baseline, cotrimoxazole use was not associated with a follow-up HAZ ≥ -2. The adjusted mean change in WAZ among children with a baseline CD4 percentage (CD4%) >25% became significantly different between cotrimoxazole and non-cotrimoxazole users after 6 months of ART and remained significant after 24 months (overall P <. 01). Similar changes in WAZ were observed in those with a baseline CD4% between 10% and 24% (overall P <. 01). Cotrimoxazole use was not associated with a significant difference in follow-up WAZ in children with a baseline CD4% <10%. In those underweight (WAZ < -2) at baseline, cotrimoxazole use was associated with a follow-up WAZ ≥ -2 (adjusted odds ratio, 1.70 vs not using cotrimoxazole [95% confidence interval, 1.28-2.25], P <. 01). This association was driven by children with a baseline CD4% ≥10%. Conclusions. Cotrimoxazole use is associated with benefits to WAZ but not HAZ during early ART in Asian children.